-

Objective & Hypothesis:Leukoplakia considered as the most common premalignant oral lesion of the oral cavity and defined as, “a white patch or plaque that cannot be characterized clinically as any other disease”.

📊

Key Findings & Data:Precancerous lesions including oral leukoplakia have a benign biological, but the histopathological examination demonstrates atypical cells confined to the epidermis.

💡

Conclusion & Impact:In this case transformation of leukoplakia into oral squamous cell carcinoma is reported.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Lökoplaki · malign transformasyon · oral kanser

Abstract

Leukoplakia considered as the most common premalignant oral lesion of the oral cavity and defined as, “a white patch or plaque that cannot be characterized clinically as any other disease”. Precancerous lesions including oral leukoplakia have a benign biological, but the histopathological examination demonstrates atypical cells confined to the epidermis. These lesions have carcinogenic potential. Patients should be followed up in terms of malignancy risk. In this case transformation of leukoplakia into oral squamous cell carcinoma is reported.

Özet

ÖZOral lökoplaki, oral mukozada en sık görülen premalign lezyon olup klinik ya da patolojik olarak herhangi bir hastalığa ait olmayan beyaz-gri plaklar ile karakterizedir. Lökoplakinin de dahil olduğu premalign lezyonlar, biyolojik davranışı selim olan ancak histopatolojik olarak hücrelerde atipi kriterleri ve maligniteye dönüşme potansiyeli taşıyan lezyonlardır. Premalign lezyonların başlangıcından itibaren düşük dereceli maligniteler olarak değerlendirilerek belirli aralıklarla takip edilmeleri önerilmektedir. Bu olguda oral lökoplaki tanısıyla takip edilen hastada lökoplakinin malign transformasyon ile oral skuamoz hücreli karsinom gelişimi göstermesi rapor edilmiştir.Anahtar kelimeler: Lökoplaki, malign transformasyon, oral kanserABSTRACTLeukoplakia considered as the most common premalignant oral lesion of the oral cavity and defined as, "a white patch or plaque that cannot be characterized clinically as any other disease". Precancerous lesions including oral leukoplakia have a benign biological, but the histopathological examination demonstrates atypical cells confined to the epidermis. These lesions have carcinogenic potential. Patients should be followed up in terms of malignancy risk. In this case transformation of leukoplakia into oral squamous cell carcinoma is reported.Keywords: Leukoplakia, malign transformation, oral cancer

Keywords

Lökoplaki malign transformasyon oral kanser Leukoplakia malign transformation oral cancer

🔖

Cite This Article

SARUHANOĞLU, A., ALTIN, N., ERGUN, S., TANYERİ, H. (2013). -. European Oral Research, Cilt: 47 - Sayı: 2, 50–56. https://ajindex.com/articles/243392

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (9)

Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY, Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients. BMC Cancer, 2010; 10: 685. Papadimitrakopoulou VA, Hong WK, Lee JS, Martin JW, Lee JJ, Batsakis JG, Lippman SM. Low-dose isotretinoin versus beta-carotene to prevent oral carcinogenesis: long-term follow-up. J Natl Cancer Inst, 1997; 89(3): 257–58.
Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA. Molecular genetics of premalignant oral lesions. Oral Dis, 2007; 13(2): 126-33. Reibel J. Prognosis of oral premalignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med, 2003; 14(1): 47-62. Sciubba JJ. Oral cancer. The importance of early diagnosis and treatment. Am J Clin Dermatol, 2001; 2(4): 239-51. van der Waal I, Schepman KP, van der Meij EH, Smeele LE. Oral leukoplakia: a clinicopathological review. Oral Oncol, 1997; 33(5): 291-301.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med, 2007; 36(10): 575–80. Petti S. Pooled estimate of world leukoplakia prevalence: a systematic review. Oral Oncol, 2003; 39(8): 770-80.
Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg, 2001; 30(1): 49–53.
Fischer DJ, Epstein JB, Morton TH, Schwartz SM. Interobserver reliability in the histopathologic diagnosis of oral premalignant and malignant lesions. J Oral Pathol Med, 2004; 33(2): 65-70.
Sarp JP, Eversole LR, Wysocki GP. Contemporary oral and maxillofacial pathology. St. Louis: Mosby, 1997, p.156-95.
Ma N, Tagawa T, Hiraku Y, Murata M, Ding X, Kawanishi S. 8-Nitroguanine formation in oral leukoplakia a premalignant lesion. Nitric Oxide, 2006; 14(2): 137–43. Huber MA. White oral lesions, actinic cheilitis, and leukoplakia: confusions in terminology and definition: facts and controversies. Clin Dermatol, 2010; 28(3): 262–68.
Öztürk B, Coşkun U, Yaman E, Kaya AO, Yıldız R, Benekli M, Büyükberber S. Oral kavite kanserlerinde risk faktörleri, premalign lezyonlar ve kemoprevensiyon. UHOD, 2009; 19(2): 117-26.
Waldron CA, Shafer WG. Leukoplakia revisited: a clinicopathologic study 3256 oral leukoplakias. Cancer, 1975; 36(4): 1386Martorell-Calatayud A, Botella-Estrada R, Bagán-Sebastián JV, Sanmartín